Steven P Marso

  • 14346 Citations
  • 48 h-Index
19982019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1998 2019

  • 14346 Citations
  • 48 h-Index
  • 169 Article
  • 3 Chapter
  • 3 Letter
  • 1 Editorial
2019
3 Citations (Scopus)

A Detailed Analysis of Perforations During Chronic Total Occlusion Angioplasty

OPEN-CTO Study Group, Oct 14 2019, In : JACC: Cardiovascular Interventions. 12, 19, p. 1902-1912 11 p.

Research output: Contribution to journalArticle

Percutaneous Coronary Intervention
Angioplasty
Cardiac Tamponade
Pericardial Effusion
Registries
2 Citations (Scopus)
Hypoglycemia
Type 2 Diabetes Mellitus
Safety
Mortality
Age Groups
12 Citations (Scopus)

Improved Outcomes Associated with the use of Shock Protocols: Updates from the National Cardiogenic Shock Initiative

on behalf of the National Cardiogenic Shock Initiative Investigators, Jun 1 2019, In : Catheterization and Cardiovascular Interventions. 93, 7, p. 1173-1183 11 p.

Research output: Contribution to journalArticle

Open Access
Cardiogenic Shock
Shock
Myocardial Infarction
Percutaneous Coronary Intervention
Cardiac Output
Open Access
Cost-Benefit Analysis
Costs and Cost Analysis
Quality-Adjusted Life Years
National Health Programs
England
1 Citation (Scopus)

Quality of Life Changes After Chronic Total Occlusion Angioplasty in Patients With Baseline Refractory Angina

Hirai, T., Grantham, J. A., Sapontis, J., Cohen, D. J., Marso, S. P., Lombardi, W., Karmpaliotis, D., Moses, J., Nicholson, W. J., Pershad, A., Wyman, R. M., Spaedy, A., Cook, S., Doshi, P., Federici, R., Nugent, K., Gosch, K. L., Spertus, J. A. & Salisbury, A. C., Mar 1 2019, In : Circulation. Cardiovascular interventions. 12, 3, p. e007558

Research output: Contribution to journalArticle

Angioplasty
Quality of Life
Percutaneous Coronary Intervention
Health Status
Quality Improvement
2018
8 Citations (Scopus)

Cardiovascular outcomes in patients who experienced a myocardial infarction while treated with liraglutide versus placebo in the LEADER trial

Nauck, M. A., Tornøe, K., Rasmussen, S., Treppendahl, M. B. & Marso, S. P., Jun 1 2018, (Accepted/In press) In : Diabetes and Vascular Disease Research.

Research output: Contribution to journalArticle

Myocardial Infarction
Placebos
Hospitalization
Heart Failure
Confidence Intervals
3 Citations (Scopus)

Changes in Heart Rate Associated with Exenatide Once Weekly: Pooled Analysis of Clinical Data in Patients with Type 2 Diabetes

Marso, S. P., Hardy, E., Han, J., Wang, H. & Chilton, R. J., Apr 1 2018, In : Diabetes Therapy. 9, 2, p. 551-564 14 p.

Research output: Contribution to journalArticle

Type 2 Diabetes Mellitus
Heart Rate
Peptide Receptors
exenatide
pioglitazone
5 Citations (Scopus)

DEVOTE 5: Evaluating the Short-Term Cost-Utility of Insulin Degludec Versus Insulin Glargine U100 in Basal–Bolus Regimens for Type 2 Diabetes in the UK

On Behalf Of The Devote Study Group, Jun 1 2018, In : Diabetes Therapy. 9, 3, p. 1217-1232 16 p.

Research output: Contribution to journalArticle

Type 2 Diabetes Mellitus
Costs and Cost Analysis
Quality-Adjusted Life Years
Cost Savings
Risk Reduction Behavior
22 Citations (Scopus)

Effect of liraglutide on cardiovascular events in patients with type 2 diabetes mellitus and polyvascular disease results of the LEADER trial

LEADER Publication Committee on behalf of the LEADER Trial Investigators, Jan 1 2018, In : Circulation. 137, 20, p. 2179-2183 5 p.

Research output: Contribution to journalArticle

Glucagon-Like Peptide 1
Type 2 Diabetes Mellitus
Atherosclerosis
Diabetes Mellitus
Myocardial Infarction
17 Citations (Scopus)

Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke

Verma, S., Poulter, N. R., Bhatt, D. L., Bain, S. C., Buse, J. B., Leiter, L. A., Nauck, M. A., Pratley, R. E., Zinman, B., Ørsted, D. D., Monk Fries, T., Rasmussen, S. & Marso, S. P., Dec 18 2018, In : Circulation. 138, 25, p. 2884-2894 11 p.

Research output: Contribution to journalArticle

Type 2 Diabetes Mellitus
Stroke
Myocardial Infarction
Cardiovascular Diseases
Liraglutide
26 Citations (Scopus)

Hypoglycemia, Cardiovascular Outcomes, and Death: The LEADER Experience

LEADER Publication Committee on behalf of the LEADER Trial Investigators, Aug 1 2018, In : Diabetes Care. 41, 8, p. 1783-1791 9 p.

Research output: Contribution to journalArticle

Hypoglycemia
Placebos
Cause of Death
Liraglutide
Incidence
10 Citations (Scopus)

Liraglutide Reduces Cardiovascular Events and Mortality in Type 2 Diabetes Mellitus Independently of Baseline Low-Density Lipoprotein Cholesterol Levels and Statin Use

Verma, S., Leiter, L. A., Mazer, C. D., Bain, S. C., Buse, J., Marso, S. P., Nauck, M., Zinman, B., Bosch-Traberg, H., Rasmussen, S., Michelsen, M. M. & Bhatt, D. L., Oct 9 2018, In : Circulation. 138, 15, p. 1605-1607 3 p.

Research output: Contribution to journalLetter

Hydroxymethylglutaryl-CoA Reductase Inhibitors
LDL Cholesterol
Type 2 Diabetes Mellitus
Diabetes Mellitus
Mortality
8 Citations (Scopus)

Myocardial Infarction Subtypes in Patients With Type 2 Diabetes Mellitus and the Effect of Liraglutide Therapy (from the LEADER Trial)

LEADER Publication Committee on behalf of the LEADER Trial Investigators, Jan 1 2018, (Accepted/In press) In : American Journal of Cardiology.

Research output: Contribution to journalArticle

Type 2 Diabetes Mellitus
Myocardial Infarction
Placebos
Therapeutics
Troponin
1 Citation (Scopus)

Relationship between left main coronary artery plaque burden and nonleft main coronary atherosclerosis: Results from the PROSPECT study

Shimizu, T., Mintz, G. S., De Bruyne, B., Farhat, N. Z., Inaba, S., Cao, Y., Marso, S. P., Weisz, G., Serruys, P. W., Stone, G. W. & Maehara, A., Aug 1 2018, In : Coronary Artery Disease. 29, 5, p. 397-402 6 p.

Research output: Contribution to journalArticle

Coronary Artery Disease
Coronary Vessels
Atherosclerotic Plaques
Atherosclerosis
Confidence Intervals

Treating Leave Behind Lesions

Marso, S. P., Oct 1 2018, In : Circulation. Cardiovascular interventions. 11, 10, p. e007367

Research output: Contribution to journalEditorial

Atherectomy
Percutaneous Coronary Intervention
Coronary Artery Disease
Cardiologists
2017
27 Citations (Scopus)

Baseline characteristics of patients enrolled in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)

Mentz, R. J., Bethel, M. A., Gustavson, S., Thompson, V. P., Pagidipati, N. J., Buse, J. B., Chan, J. C., Iqbal, N., Maggioni, A. P., Marso, S. P., Ohman, P., Poulter, N., Ramachandran, A., Zinman, B., Hernandez, A. F. & Holman, R. R., May 1 2017, In : American Heart Journal. 187, p. 1-9 9 p.

Research output: Contribution to journalArticle

Placebos
Dipeptidyl-Peptidase IV Inhibitors
Cerebrovascular Disorders
Latin America
Peripheral Arterial Disease
16 Citations (Scopus)

Comparative Efficacy of Endovascular Revascularization Versus Supervised Exercise Training in Patients With Intermittent Claudication: Meta-Analysis of Randomized Controlled Trials

Pandey, A., Banerjee, S., Ngo, C., Mody, P., Marso, S. P., Brilakis, E. S., Armstrong, E. J., Giri, J., Bonaca, M. P., Pradhan, A., Bavry, A. A. & Kumbhani, D. J., Apr 10 2017, In : JACC: Cardiovascular Interventions. 10, 7, p. 712-724 13 p.

Research output: Contribution to journalArticle

Intermittent Claudication
Meta-Analysis
Randomized Controlled Trials
Exercise
Amputation
46 Citations (Scopus)

Costs Associated With Access Site and Same-Day Discharge Among Medicare Beneficiaries Undergoing Percutaneous Coronary Intervention: An Evaluation of the Current Percutaneous Coronary Intervention Care Pathways in the United States

Amin, A. P., Patterson, M., House, J. A., Giersiefen, H., Spertus, J. A., Baklanov, D. V., Chhatriwalla, A. K., Safley, D. M., Cohen, D. J., Rao, S. V. & Marso, S. P., Feb 27 2017, In : JACC: Cardiovascular Interventions. 10, 4, p. 342-351 10 p.

Research output: Contribution to journalArticle

Percutaneous Coronary Intervention
Costs and Cost Analysis
Confidence Intervals
Hospital Costs
Medicare
53 Citations (Scopus)

Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2)

On Behalf Of The Devote Study Group, Sep 15 2017, (Accepted/In press) In : Diabetologia. p. 1-10 10 p.

Research output: Contribution to journalArticle

Hypoglycemia
Fasting
Breakfast
Blood Glucose
Mortality
47 Citations (Scopus)

DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality

On Behalf Of The Devote Study Group, Sep 15 2017, (Accepted/In press) In : Diabetologia. p. 1-8 8 p.

Research output: Contribution to journalArticle

Hypoglycemia
Mortality
Type 2 Diabetes Mellitus
Safety
Hypoglycemic Agents
67 Citations (Scopus)

Early Procedural and Health Status Outcomes After Chronic Total Occlusion Angioplasty: A Report From the OPEN-CTO Registry (Outcomes, Patient Health Status, and Efficiency in Chronic Total Occlusion Hybrid Procedures)

Sapontis, J., Salisbury, A. C., Yeh, R. W., Cohen, D. J., Hirai, T., Lombardi, W., McCabe, J. M., Karmpaliotis, D., Moses, J., Nicholson, W. J., Pershad, A., Wyman, R. M., Spaedy, A., Cook, S., Doshi, P., Federici, R., Thompson, C. R., Marso, S. P., Nugent, K., Gosch, K. & 2 others, Spertus, J. A. & Grantham, J. A., Aug 14 2017, In : JACC: Cardiovascular Interventions. 10, 15, p. 1523-1534 12 p.

Research output: Contribution to journalArticle

Percutaneous Coronary Intervention
Health Status
Registries
Quality of Life
Insurance Benefits
477 Citations (Scopus)

Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes

EXSCEL Study Group, Sep 28 2017, In : New England Journal of Medicine. 377, 13, p. 1228-1239 12 p.

Research output: Contribution to journalArticle

Type 2 Diabetes Mellitus
Placebos
Cardiovascular Diseases
Cause of Death
Hospitalization
229 Citations (Scopus)

Efficacy and safety of degludec versus Glargine in Type 2 Diabetes

Marso, S. P., McGuire, D. K., Zinman, B., Poulter, N. R., Emerson, S. S., Pieber, T. R., Pratley, R. E., Haahr, P. M., Lange, M., Brown-Frandsen, K., Moses, A., Skibsted, S., Kvist, K. & Buse, J. B., Aug 24 2017, In : New England Journal of Medicine. 377, 8, p. 723-732 10 p.

Research output: Contribution to journalArticle

Type 2 Diabetes Mellitus
Safety
Hypoglycemia
Glycosylated Hemoglobin A
Insulin
11 Citations (Scopus)

Impact of subintimal plaque modification procedures on health status after unsuccessful chronic total occlusion angioplasty

Hirai, T., Grantham, J. A., Sapontis, J., Cohen, D. J., Marso, S. P., Lombardi, W., Karmpaliotis, D., Moses, J., Nicholson, W. J., Pershad, A., Wyman, R. M., Spaedy, A., Cook, S., Doshi, P., Federici, R., Nugent, K., Gosch, K. L., Spertus, J. A. & Salisbury, A. C., 2017, (Accepted/In press) In : Catheterization and Cardiovascular Interventions.

Research output: Contribution to journalArticle

Angioplasty
Health Status
Registries
Dissection
Safety
8 Citations (Scopus)

Liraglutide and cardiovascular outcomes in adults with overweight or obesity: A post hoc analysis from SCALE randomized controlled trials

Davies, M. J., Aronne, L. J., Caterson, I. D., Thomsen, A. B., Jacobsen, P. B. & Marso, S. P., 2017, (Accepted/In press) In : Diabetes, Obesity and Metabolism.

Research output: Contribution to journalArticle

Randomized Controlled Trials
Obesity
Placebos
Confidence Intervals
Controlled Clinical Trials
275 Citations (Scopus)

Liraglutide and renal outcomes in type 2 diabetes

LEADER Steering Committee and Investigators, Aug 31 2017, In : New England Journal of Medicine. 377, 9, p. 839-848 10 p.

Research output: Contribution to journalArticle

Type 2 Diabetes Mellitus
Kidney
Placebos
Randomized Controlled Trials
Confidence Intervals

Revascularization Approaches

Marso, S. P., Mar 3 2017, Chronic Coronary Artery Disease: A Companion to Braunwald's Heart Disease. Elsevier, p. 337-354 18 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

3 Citations (Scopus)

Safety of degludec versus glargine in type 2 diabetes

Marso, S. P. & Buse, J. B., Nov 16 2017, In : New England Journal of Medicine. 377, 20, p. 1995-1996 2 p.

Research output: Contribution to journalLetter

Type 2 Diabetes Mellitus
Safety
Insulin Glargine
insulin degludec
20 Citations (Scopus)

The authors reply

Marso, S. P., Holst, A. G. & Vilsbøll, T., Mar 2 2017, In : New England Journal of Medicine. 376, 9, p. 891-892 2 p.

Research output: Contribution to journalLetter

2016
3 Citations (Scopus)

Association between health status and long-term mortality after percutaneous revascularization of peripheral artery disease

Bunte, M. C., House, J. A., Spertus, J. A., Cohen, D. J., Marso, S. P. & Safley, D. M., May 1 2016, In : Catheterization and Cardiovascular Interventions. 87, 6, p. 1149-1155 7 p.

Research output: Contribution to journalArticle

Peripheral Arterial Disease
Health Status
Survival
Mortality
Therapeutics
32 Citations (Scopus)

Design of DEVOTE (Trial Comparing Cardiovascular Safety of Insulin Degludec vs Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events) – DEVOTE 1

Marso, S. P., McGuire, D. K., Zinman, B., Poulter, N. R., Emerson, S. S., Pieber, T. R., Pratley, R. E., Haahr, P. M., Lange, M., Frandsen, K. B., Rabøl, R. & Buse, J. B., Sep 1 2016, In : American Heart Journal. 179, p. 175-183 9 p.

Research output: Contribution to journalArticle

Type 2 Diabetes Mellitus
Safety
Random Allocation
Chronic Renal Insufficiency
Cardiovascular Diseases

How to fix common problems encountered in CTO PCI: The expanded hybrid approach

Sapontis, J., Marso, S. P., Lombardi, W. L. & Aaron Grantham, J., Jan 1 2016, Percutaneous Intervention for Coronary Chronic Total Occlusion: The Hybrid Approach. Springer International Publishing, p. 141-159 19 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Percutaneous Coronary Intervention
Cardiology
Safety
Costs and Cost Analysis
6 Citations (Scopus)

Influence of total coronary occlusion on clinical outcomes (from the Bypass Angioplasty Revascularization Investigation 2 DiabetesTrial)

Damluji, A. A., Pomenti, S. F., Ramireddy, A., Al-Damluji, M. S., Alfonso, C. E., Schob, A. H., Marso, S. P., Gilchrist, I. C., Moscucci, M., Kandzari, D. E. & Cohen, M. G., Apr 1 2016, In : American Journal of Cardiology. 117, 7, p. 1031-1038 8 p.

Research output: Contribution to journalArticle

Coronary Occlusion
Angioplasty
Coronary Artery Bypass
Coronary Disease
Diabetes Mellitus
6 Citations (Scopus)

LEADER-4: blood pressure control in patients with type 2 diabetes and high cardiovascular risk: baseline data from the LEADER randomized trial

on behalf of the LEADER investigators, Feb 5 2016, (Accepted/In press) In : Journal of Hypertension.

Research output: Contribution to journalArticle

Type 2 Diabetes Mellitus
Blood Pressure
Cardiovascular Diseases
Random Allocation
Antihypertensive Agents
26 Citations (Scopus)
Type 2 Diabetes Mellitus
Waist Circumference
Body Mass Index
Obesity
Antihypertensive Agents
6 Citations (Scopus)

LEADER 7: Cardiovascular risk profiles of US and European participants in the LEADER diabetes trial differ

Rutten, G. E. H. M., Tack, C. J., Pieber, T. R., Comlekci, A., Ørsted, D. D., Baeres, F. M. M., Marso, S. P. & Buse, J. B., Jun 2 2016, In : Diabetology and Metabolic Syndrome. 8, 1, 37.

Research output: Contribution to journalArticle

Cardiovascular Diseases
Blood Pressure
LDL Cholesterol
Glycosylated Hemoglobin A
Risk Management
2252 Citations (Scopus)

Liraglutide and cardiovascular outcomes in type 2 diabetes

LEADER Steering Committee on behalf of the LEADER Trial Investigators, Jul 28 2016, In : New England Journal of Medicine. 375, 4, p. 311-322 12 p.

Research output: Contribution to journalArticle

Type 2 Diabetes Mellitus
Placebos
Confidence Intervals
Cause of Death
Stroke
49 Citations (Scopus)

Rationale and design of the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) trial

Holman, R. R., Bethel, M. A., George, J., Sourij, H., Doran, Z., Keenan, J., Khurmi, N. S., Mentz, R. J., Oulhaj, A., Buse, J. B., Chan, J. C., Iqbal, N., Kundu, S., Maggioni, A. P., Marso, S. P., Öhman, P., Pencina, M. J., Poulter, N., Porter, L. E., Ramachandran, A. & 2 others, Zinman, B. & Hernandez, A. F., Apr 1 2016, In : American Heart Journal. 174, p. 103-110 8 p.

Research output: Contribution to journalArticle

Type 2 Diabetes Mellitus
exenatide
Placebos
Safety
Subcutaneous Injections
16 Citations (Scopus)

Revascularization trends in patients with diabetes mellitus and multivessel coronary artery disease presenting with non-ST elevation myocardial infarction

Pandey, A., McGuire, D. K., de Lemos, J. A., Das, S. R., Berry, J. D., Brilakis, E. S., Banerjee, S., Marso, S. P., Barsness, G. W., Simon, D. J. N., Roe, M., Goyal, A., Kosiborod, M., Amsterdam, E. A. & Kumbhani, D. J., May 1 2016, In : Circulation: Cardiovascular Quality and Outcomes. 9, 3, p. 197-205 9 p.

Research output: Contribution to journalArticle

Percutaneous Coronary Intervention
Coronary Artery Bypass
Coronary Artery Disease
Diabetes Mellitus
Transplants
1364 Citations (Scopus)

Semaglutide and cardiovascular outcomes in patients with type 2 diabetes

Marso, S. P., Bain, S. C., Consoli, A., Eliaschewitz, F. G., Jodar, E., Leiter, L. A., Lingvay, I., Rosenstock, J., Seufert, J., Warren, M. L., Woo, V., Hansen, O., Holst, A. G., Pettersson, J. & Vilsboll, T., Nov 10 2016, In : New England Journal of Medicine. 375, 19, p. 1834-1844 11 p.

Research output: Contribution to journalArticle

Type 2 Diabetes Mellitus
Placebos
Confidence Intervals
Stroke
Myocardial Infarction
10 Citations (Scopus)

The Impact of Bleeding Avoidance Strategies on Hospital-Level Variation in Bleeding Rates Following Percutaneous Coronary Intervention Insights from the National Cardiovascular Data Registry CathPCI Registry

Vora, A. N., Peterson, E. D., McCoy, L. A., Garratt, K. N., Kutcher, M. A., Marso, S. P., Roe, M. T., Messenger, J. C. & Rao, S. V., Apr 25 2016, In : JACC: Cardiovascular Interventions. 9, 8, p. 771-779 9 p.

Research output: Contribution to journalArticle

Percutaneous Coronary Intervention
Registries
Hemorrhage
24 Citations (Scopus)

The Outcomes, Patient Health Status, and Efficiency IN Chronic Total Occlusion Hybrid Procedures registry: rationale and design

on behalf of the OPEN CTO Study Group, Oct 13 2016, (Accepted/In press) In : Coronary Artery Disease.

Research output: Contribution to journalArticle

Health Status
Registries
Cardiovascular Diseases
Percutaneous Coronary Intervention
Cost-Benefit Analysis
2015
32 Citations (Scopus)
Diastolic Heart Failure
Mineralocorticoid Receptor Antagonists
Meta-Analysis
Heart Failure
Left Ventricular Function

Erratum: FIRST: Fractional Flow Reserve and Intravascular Ultrasound Relationship Study (Journal of the American College of Cardiology (2013) 61(917-23))

Waksman, R., Legutk, J., Singh, J., Orlando, Q., Marso, S., Schloss, T., Tugaoen, J., DeVries, J., Palmer, N., Haude, M., Swymelar, S. & Torguson, R., Jul 21 2015, In : Journal of the American College of Cardiology. 66, 3, p. 335 1 p.

Research output: Contribution to journalArticle

Evaluation des effets cardiovasculaires du liraglutide: conception et donnees de base de l'etude Liraglutide effect and action in diabetes: Evaluation of cardiovascular outcome results (LEADER®)

Translated title of the contribution: Design of the Liraglutide effect and action in diabetes: Evaluation of cardiovascular outcome results (LEADER® trial)Marre, M., Marso, S. P., Poulter, N. R., Nissen, S. E., Nauck, M. A., Zinman, B., Daniels, G. H., Pocock, S., Steinberg, W. M., Bergenstal, R. M., Mann, J. F. E., Steen Ravn, L., Brown Frandsen, K., Moses, A. C. & Buse, J. B., 2015, In : Medecine des Maladies Metaboliques. 9, 3, p. 316-328 13 p.

Research output: Contribution to journalArticle

Random Allocation
Type 2 Diabetes Mellitus
Stroke
Myocardial Infarction
Placebos
3 Citations (Scopus)
Atherectomy
Excimer Lasers
Percutaneous Coronary Intervention
Equipment and Supplies
Stents
11 Citations (Scopus)

Impact of TCFA on Unanticipated Ischemic Events in Medically Treated Diabetes Mellitus. Insights From the PROSPECT Study

Kedhi, E., Kennedy, M. W., Maehara, A., Lansky, A. J., McAndrew, T. C., Marso, S. P., De Bruyne, B., Serruys, P. W. & Stone, G. W., Sep 28 2015, (Accepted/In press) In : JACC: Cardiovascular Imaging.

Research output: Contribution to journalArticle

Diabetes Mellitus
Acute Coronary Syndrome
Confidence Intervals
Propensity Score
Research Design
9 Citations (Scopus)
Calcitonin
Type 2 Diabetes Mellitus
Serum
Glomerular Filtration Rate
Liraglutide
15 Citations (Scopus)

Predictors of plaque rupture within nonculprit fibroatheromas in patients with acute coronary syndromes the PROSPECT Study

Zheng, B., Mintz, G. S., McPherson, J. A., De Bruyne, B., Farhat, N. Z., Marso, S. P., Serruys, P. W., Stone, G. W. & Maehara, A., Oct 1 2015, In : JACC: Cardiovascular Imaging. 8, 10, p. 1180-1187 8 p.

Research output: Contribution to journalArticle

Acute Coronary Syndrome
Rupture
Odds Ratio
Confidence Intervals
Coronary Vessels